| Misty Boudreaux, | |
|
180 W Esplanade Ave, Kenner, LA 70065-2467 | |
| (504) 468-8600 | |
| Not Available |
| Full Name | Misty Boudreaux |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 10 Years |
| Location | 180 W Esplanade Ave, Kenner, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023417722 | NPI | - | NPPES |
| 07984823 | Medicaid | MS | |
| 2373234 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | AP07975 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Medical Center-kenner | Kenner, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
A common hormone therapy to treat prostate cancer may double a man's risk of dementia, regardless of his age, Penn Medicine researchers reported in a study published online today in JAMA Oncology.
Isis Innovation, the University of Oxford's technology commercialisation company, and Ludwig Cancer Research are proud to announce the launch of a new spinout company, iOx Therapeutics. iOx Therapeutics will develop a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford's Weatherall Institute of Molecular Medicine.
Penn Medicine researchers, along with colleagues at Cincinnati Children's Hospital and Boston University, have received a $5.2 million, seven-year grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to study the cellular and molecular mechanisms that promote lung regeneration.
Scientists at The Wistar Institute have implemented a novel structurally designed synthetic DNA vaccine to simultaneously target multiple members of a family of proteins that are specifically overexpressed in several types of cancer.
› Verified 3 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
A common hormone therapy to treat prostate cancer may double a man's risk of dementia, regardless of his age, Penn Medicine researchers reported in a study published online today in JAMA Oncology.
Isis Innovation, the University of Oxford's technology commercialisation company, and Ludwig Cancer Research are proud to announce the launch of a new spinout company, iOx Therapeutics. iOx Therapeutics will develop a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford's Weatherall Institute of Molecular Medicine.
Penn Medicine researchers, along with colleagues at Cincinnati Children's Hospital and Boston University, have received a $5.2 million, seven-year grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to study the cellular and molecular mechanisms that promote lung regeneration.
Scientists at The Wistar Institute have implemented a novel structurally designed synthetic DNA vaccine to simultaneously target multiple members of a family of proteins that are specifically overexpressed in several types of cancer.
› Verified 3 days ago
| Entity Name | Louisiana State University School Of Medicine In New Orleans Faculty G |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477582526 PECOS PAC ID: 0244136448 Enrollment ID: O20031209000661 |
News Archive
A common hormone therapy to treat prostate cancer may double a man's risk of dementia, regardless of his age, Penn Medicine researchers reported in a study published online today in JAMA Oncology.
Isis Innovation, the University of Oxford's technology commercialisation company, and Ludwig Cancer Research are proud to announce the launch of a new spinout company, iOx Therapeutics. iOx Therapeutics will develop a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford's Weatherall Institute of Molecular Medicine.
Penn Medicine researchers, along with colleagues at Cincinnati Children's Hospital and Boston University, have received a $5.2 million, seven-year grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to study the cellular and molecular mechanisms that promote lung regeneration.
Scientists at The Wistar Institute have implemented a novel structurally designed synthetic DNA vaccine to simultaneously target multiple members of a family of proteins that are specifically overexpressed in several types of cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Misty Boudreaux, 6875 West End Blvd, New Orleans, LA 70124 Ph: (504) 655-1012 | Misty Boudreaux, 180 W Esplanade Ave, Kenner, LA 70065-2467 Ph: (504) 468-8600 |
News Archive
A common hormone therapy to treat prostate cancer may double a man's risk of dementia, regardless of his age, Penn Medicine researchers reported in a study published online today in JAMA Oncology.
Isis Innovation, the University of Oxford's technology commercialisation company, and Ludwig Cancer Research are proud to announce the launch of a new spinout company, iOx Therapeutics. iOx Therapeutics will develop a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford's Weatherall Institute of Molecular Medicine.
Penn Medicine researchers, along with colleagues at Cincinnati Children's Hospital and Boston University, have received a $5.2 million, seven-year grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to study the cellular and molecular mechanisms that promote lung regeneration.
Scientists at The Wistar Institute have implemented a novel structurally designed synthetic DNA vaccine to simultaneously target multiple members of a family of proteins that are specifically overexpressed in several types of cancer.
› Verified 3 days ago
Angela W Kilbourn, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 180 W Esplanade Ave, Kenner, LA 70065 Phone: 504-842-3755 Fax: 504-842-2036 | |
Ms. Charlene V Brouillette, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5024 Toby Ln, Kenner, LA 70065 Phone: 504-456-9958 Fax: 504-779-6769 | |
Dana Pierce, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 180 W Esplanade Ave, Kenner, LA 70065 Phone: 504-842-3755 | |
Latania Z Austin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 W Esplanade Ave, Kenner, LA 70065 Phone: 504-464-8506 | |
Jonah Parker Borskey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 180 W Esplanade Ave, Kenner, LA 70065 Phone: 504-468-8600 | |
Micah J Metrailer, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 200 W Esplanade Ave, Kenner, LA 70065 Phone: 504-464-8506 |